series-b
Stage
2
Investors
About
Arecor is a clinical-stage biopharmaceutical company developing superior therapeutics that reduce treatment burden and improve outcomes for people living with diabetes, obesity, and other cardiometabolic diseases, utilizing its proprietary Arestat® technology platform for innovative drug formulation and delivery.
Explore Arecor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.